Persbericht: Programma bekend van gebruikersevent GiLab Commit 2019
Amsterdam — 30 augustus 2019 — GitLab, het DevOps platform,... Lees verder →
Data demonstrate AT-100 (rhSP-D) -- novel human recombinant protein -- reduces infection in a range of bacteria and virus-driven respiratory diseases with potential to treat ...
Lees verder- Investigational oral MET inhibitor has previously received SAKIGAKE 'fast-track' regulatory designation in Japan - MET exon 14 skipping alterations and MET amplifications ...
Lees verderAACHEN, Germany, and MELBOURNE, Australia, Sept. 10, 2019 /PRNewswire/ -- Grünenthal, a global leader in pain management, and Mesoblast Limited , a world leader in allogeneic ...
Lees verderMELBOURNE, Australia, July 5, 2019 /PRNewswire/ -- The International Society on Thrombosis and Haemostasis (ISTH) is pleased to announce the official launch of Gene Therapy ...
Lees verderASCO Abstract # Tepotinib (MET kinase inhibitor): 9005 Not intended for UK- , Canada- or US-based media DARMSTADT, Germany, June 3, 2019 /PRNewswire/ -- -- ...
Lees verderPlus, Sex-Based Approaches May Improve Diagnostic Accuracy in Alzheimer's CHICAGO, July 23, 2018 /PRNewswire/ -- Research reported at the Alzheimer's Association International ...
Lees verderOSAKA, Japan, June 3, 2018 /PRNewswire/ -- Takeda demonstrates leadership in GI by featuring new U.S. VICTORY Consortium data among its 24 sponsored Entyvio abstracts ...
Lees verderOSAKA, Japan, February 16, 2018 /PRNewswire/ -- New clinical study also provides data for Entyvio(R) in inducing complete mucosal healing and endoscopic remission, ...
Lees verderDARMSTADT, Germany and NEW YORK, December 21, 2017 /PRNewswire/ -- - Second Breakthrough Therapy Designation for avelumab in hard-to-treat cancer - Renal ...
Lees verderBROOKLYN PARK, Minnesota, Oct. 24, 2017 /PRNewswire/ -- 4C Medical Technologies, Inc. (4C Medical), a developer of minimally invasive technologies for structural heart disease, ...
Lees verder